JP Morgan Chase’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History
Bought
Maintained
Sold
Other funds holding PEPL
RCM
SCM
SIM
ACM
PAMP
AA
RCM
BFM
TI
JP Morgan Chase's PEPL Position: Q1 2023 in Review
JP Morgan Chase sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 17,980 shares — an estimated $184K sold.
JP Morgan Chase first reported a position in PEPL in Q1 2022 and held it in 4 quarters. The position peaked at $3.64M in Q1 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.
- JP Morgan Chase reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
- JP Morgan Chase sold 17,980 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $184K.
- JP Morgan Chase first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022 and held it in 4 quarters.
- JP Morgan Chase's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $3.64M in Q1 2022.
- 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.